Proteasome inhibitor MG132 inhibits angiogenesis in pancreatic cancer by blocking NF-kappaB activity

Matsuo, Yoichi; Sawai, Hirozumi; Ochi, Nobuo; Yasuda, Akira; Sakamoto, Masaki; Takahashi, Hiroki; Funahashi, Hitoshi; Takeyama, Hiromitsu; Guha, Sushovan
April 2010
Digestive Diseases & Sciences;Apr2010, Vol. 55 Issue 4, p1167
Academic Journal
journal article
Since angiogenesis enables solid tumors, including pancreatic cancer (PaCa), to grow and metastasize, the development of anti-angiogenic agents is currently one of the urgent issues. Proteasome inhibitors are well known for inhibiting nuclear factor-kappa B (NF-kappaB) activity in various cancer cells, but little is known about their biologic mechanisms against angiogenesis in PaCa. We divided human PaCa cell lines into high-angiogenic (BxPC-3 and SW 1990) and low-angiogenic (MIA PaCa-2 and Capan-2) groups. The high-angiogenic PaCa cell lines constitutively expressed high NF-kappaB activity and produced high levels of vascular endothelial growth factor (VEGF) and interleukin 8 (IL-8). The conditioned media from BxPC-3 significantly enhanced both proliferation of and tube formation by human umbilical vein endothelial cells (HUVECs) and these enhancements were significantly inhibited by the proteasome inhibitor MG132 treatment. Collectively, MG132 blocked PaCa-derived VEGF and IL-8 production through inhibition of NF-kappaB activity. Thus, proteasome inhibitors may prove beneficial as anti-angiogenic therapy for PaCa. Our studies show that MG132, a proteasome inhibitor, significantly blocked pancreatic-cancer-associated angiogenesis through inhibition of NF-kappaB and NF-kappaB-dependent proangiogenic gene products VEGF and IL-8.


Related Articles

  • Suppression of Erosive Arthritis by NF-?B Inhibitors. Kubota, Tetsuo; Umezawa, Kazuo // Current Rheumatology Reviews;2011, Vol. 7 Issue 4, p275 

    Excess activation of NF-kappa B is often involved in inflammation and cancer progression. We have developed a specific NF-kappa B inhibitor dehydroxyepoxyquinomicin (DHMEQ). It binds to the specific cysteine residue of Rel family proteins. DHMEQ inhibited cytokine secretions and...

  • Inhibition of NFkappaB by activated c-Jun NH2 terminal kinase 1 acts as a switch for C2C12 cell death under excessive stretch. Tan, Jiali; Kuang, Wei; Jin, Zuolin; Jin, Fang; Xu, Lin; Yu, Qiujun; Kong, Liang; Zeng, Guang; Yuan, Xiao; Duan, Yinzhong // Apoptosis;Jun2009, Vol. 14 Issue 6, p764 

    Mechanical stimuli play an important role in adaptive response of skeletal muscles, while inappropriate stretches result in apoptosis. In this study, we investigated the contribution of cyclic stretches to apoptosis of myoblast C2C12 cells. A 24-h cyclic stretch at an extension level of over...

  • Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Kwon, Guim; Corbett, John A.; Hauser, Scott; Hill, Jeanette R.; Turk, John; McDaniel, Michael L.; Kwon, G; Corbett, J A; Hauser, S; Hill, J R; Turk, J; McDaniel, M L // Diabetes;Apr1998, Vol. 47 Issue 4, p583 

    Interleukin-1beta (IL-1beta) has been implicated as an effector molecule of beta-cell destruction in autoimmune diabetes. IL-1beta inhibits insulin secretion from pancreatic beta-cells by stimulating the expression of inducible nitric oxide synthase (iNOS) that generates the free radical nitric...

  • Cancer: More than skin deep. Bolotin, Diana; Fuchs, Elaine // Nature;2/6/2003, Vol. 421 Issue 6923, p594 

    Studies the association between the nuclear factor (NF)-kappa B protein subunits and skin cancer. Regulation of NF-kappa B activity; Role of NF-kappa B in promoting cell proliferation and in protecting against programmed cell death; Mechanism underlying the interplay between NF-kappa B...

  • Resveratrol May Be a Powerful Cancer-Fighting Ally. Schultz, James // JNCI: Journal of the National Cancer Institute;10/20/2004, Vol. 96 Issue 20, p1497 

    Reports on the potential of resveratrol, an antioxidant found in high concentrations in grapes and grape skins to fight against cancer. Aid of resveratrol to control atherosclerosis, heart disease, arthritis and autoimmune disorders; Identification of the capacity of resveratrol to block cancer...

  • Arresting NF-?B byß-arrestin2. Chen, F. // Cell Death & Differentiation;Nov2004, Vol. 11 Issue 11, p1155 

    The article focuses on the activity of NF-kappa B, a ubiquitous transcription factor governing the expression of genes involved in various cellular functions during both normal physiological conditions and pathological circumstances. A number of endogenous inhibitors that restrict the activation...

  • Anti-Angiogenic and Anti-Tumor Properties of Proteasome Inhibitors. Daniel, Kenyon G.; Kuhn, Deborah J.; Kazi, Aslamuzzaman; Dou, Q. P. // Current Cancer Drug Targets;Oct2005, Vol. 5 Issue 7, p529 

    Tumor growth and metastasis depend on the formation of blood vessels, angiogenesis, to supply the developing mass with nutrients, oxygen, and waste removal. The proteasome, a massive multisubunit catabolic body, exerts a regulatory influence on angiogenesis. Inhibition of the proteasome activity...

  • The Proteasome Inhibitor MG-132 Induces AIF Nuclear Translocation Through Down-Regulation of ERK and Akt/mTOR Pathway. Ko, Jun; Choi, Chang; Kim, Yong; Kwon, Chae // Neurochemical Research;May2011, Vol. 36 Issue 5, p722 

    nticancer activity of proteasome inhibitors has been demonstrated in various cancer cell types. However, mechanisms by which they exert anticancer action were not fully understood. The present study was undertaken to examine the effect of the proteasome inhibitor MG-132 and the underlying...

  • Acylpeptide Hydrolase Inhibition as Targeted Strategy to Induce Proteasomal Down-Regulation. Palmieri, Gianna; Bergamo, Paolo; Luini, Alberto; Ruvo, Menotti; Gogliettino, Marta; Langella, Emma; Saviano, Michele; Hegde, Ramanath N.; Sandomenico, Annamaria; Rossi, Mose // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Acylpeptide hydrolase (APEH), one of the four members of the prolyl oligopeptidase class, catalyses the removal of Nacylated amino acids from acetylated peptides and it has been postulated to play a key role in protein degradation machinery. Disruption of protein turnover has been established as...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics